TP53 and neoplasm: To the best of our knowledge, this is the first in vivo study to propose a mechanism underlying the tumor-promoting function of stromal mutant p53, linking mutant p53-induced secretory factors in stromal fibroblasts to downstream biological pathways in mammary epithelial tumors that drive cell proliferation (Fig. 5).